Elsevier's Clinician of the Future 2025 survey: Clinicians’ AI usage and optimism grows despite concerns around trust and reliability

Clinicians across the world believe artificial intelligence (AI) can play an important role in addressing major healthcare challenges and easing burdens for doctors and nurses according to Elsevier’s Clinician of the Future 2025 annual insights report. With the healthcare landscape evolving rapidly and clinicians facing persistent challenges in delivering quality care, this new report shows how clinicians believe these challenges can be met in the years ahead.

Physicians and nurses are optimistic about the potential of AI to improve patient care in the next two to three years. Based on 2,206 survey responses from 109 countries, clinicians are most optimistic about the potential of clinical AI tools to save them time (70%), enhance diagnostic speed (58%) and accuracy (54%), and help improve patient outcomes (55%).

Their optimism is tempered by caution around trustworthiness and compliance with regulations, and a concern that health institutions are not keeping up with clinician demand for AI solutions.

Healthcare challenges:

• Worryingly, 28% of clinicians admit they don't have enough time to deliver quality care, driven by high patient volume. 69% of clinicians report seeing more patients now than 2 years ago, and nearly half (47%) believe tiredness has impaired their ability to treat patients effectively.

AI use increases but many still use generic tools:

• 48% of clinicians say they have used an AI tool for work, nearly double the 26% reported in last year's Clinician of the Future: Attitudes toward AI survey.

• Usage of AI for work purposes was highest amongst respondents from China (71%) and lowest in the US (36%) and UK (34%).

• 97% of AI-using clinicians reported using a generalist tool such as ChatGPT, whereas only 76% have used a specialized AI tool developed for clinical clinical-specific AI tool.

AI enthusiasm is not matched by usage:

• 95% of clinicians reported seeing a benefit in leveraging generative AI for clinical activities in last year’s Clinician of the Future: Attitudes toward AI report, and this year’s survey shows confidence that AI can help save clinicians time and help to improve patient outcomes in the next 2-3 years.

• 41% think in two to three years “clinicians using AI tools will deliver higher quality care than those that don’t”.

• However, today only 16% are using AI tools to actually help make clinical decisions. This is despite an additional 48% of Clinician of the Future 2025 participants expressing a desire to use AI to help with clinical determinations.

Trusted content builds trust in AI

• Clinicians cite several approaches that would increase trust in clinical-specific AI tools, including tools automatically citing references (68%), being trained on high-quality, peer reviewed content (65%), and utilizing the latest resources (64%).

• The desire for AI tools to be trained for factual accuracy is highest in the US (75%) and the UK (81%).

Barriers to AI access:

• Just 32% of those surveyed feel their institution provides adequate access to AI technologies, and only 30% have received sufficient training.

• A substantial need for AI management and oversight has also surfaced with only 29% of respondents indicating their organization provides adequate AI governance.

Jan Herzhoff, President of Elsevier Health, said, “As the healthcare industry continues to grapple with increased demands and limited resources, clinicians have identified many opportunities for AI to provide quality care faster and to help improve patient outcomes. This is a transformative time and we look forward to working alongside the healthcare community to harness the full potential of AI to deliver for patients.”

The Clinician of the Future Report is now in its fourth year – for more information about Clinician of the Future 2025 visit here.

エルゼビアについて

エルゼビアは、先端情報と意思決定を支援しています。1世紀以上にわたり、人類の進歩のため先端科学とヘルスケアの進歩に貢献してきました。私たちは、170か国にわたるアカデミアや企業の研究コミュニティ、医師、看護師、未来の医療従事者、教育者の皆さまの重要な活動をサポートしています。これは、信頼できるエビデンスに基づく科学・医療コンテンツと高度なAI技術を組み合わせた革新的なソリューションにより知見の集積や重要な意思決定を支援することで実現しています。また、私たちは、これらの価値を製品や企業文化に組み込み、コミュニティとの協働を通じて、インクルージョンと持続可能性を推進しています。エルゼビア財団は、世界中の研究と医療のパートナーシップを支援しています。

エルゼビアは、専門家およびビジネス向けの情報分析および意思決定ツールのグローバルプロバイダーであるRELX Groupの一事業を担っています。詳細につきましては、www.elsevier.comソーシャルメディア@Elsevier Connectをご覧ください。